Thu, Dec 05, 2024
The company's product is therapeutically equivalent to Novartis Pharmaceuticals Corporation's Votrient tablets (200 mg).
More >
Fri, Oct 18, 2024
The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal affective disorder.
Fri, Sep 20, 2024
The drug maker will respond to the USFDA within the prescribed timeframe and will work in close collaboration with it to address the observation at the earliest possible time, the company said.
Wed, Jul 17, 2024
The approval by the US Food & Drug Administration (USFDA) is for Topiramate capsules of strengths 15 mg and 25 mg, Glenmark Pharmaceuticals said in a statement.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
